Clinical Trial Detail

NCT ID NCT04262856
Title Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer (ARC-7)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Arcus Biosciences, Inc.

lung non-squamous non-small cell carcinoma

lung squamous cell carcinoma


AB154 + AB928 + GLS-010


AB154 + GLS-010

Age Groups: senior adult

Additional content available in CKB BOOST